These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16373339)
21. Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling. Wu WK; Sung JJ; Yu L; Cho CH Biochem Biophys Res Commun; 2008 Jun; 371(2):209-14. PubMed ID: 18435911 [TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein-4-induced activation of Xretpos is mediated by Smads and Olf-1/EBF associated zinc finger (OAZ). Shim S; Bae N; Han JK Nucleic Acids Res; 2002 Jul; 30(14):3107-17. PubMed ID: 12136093 [TBL] [Abstract][Full Text] [Related]
23. The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Pimanda JE; Donaldson IJ; de Bruijn MF; Kinston S; Knezevic K; Huckle L; Piltz S; Landry JR; Green AR; Tannahill D; Göttgens B Proc Natl Acad Sci U S A; 2007 Jan; 104(3):840-5. PubMed ID: 17213321 [TBL] [Abstract][Full Text] [Related]
24. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695 [TBL] [Abstract][Full Text] [Related]
25. Smad6 is essential to limit BMP signaling during cartilage development. Estrada KD; Retting KN; Chin AM; Lyons KM J Bone Miner Res; 2011 Oct; 26(10):2498-510. PubMed ID: 21681813 [TBL] [Abstract][Full Text] [Related]
26. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113 [TBL] [Abstract][Full Text] [Related]
27. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867 [TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein signaling in articular chondrocyte differentiation. Nishihara A; Fujii M; Sampath TK; Miyazono K; Reddi AH Biochem Biophys Res Commun; 2003 Feb; 301(2):617-22. PubMed ID: 12565908 [TBL] [Abstract][Full Text] [Related]
29. Bone Morphogenetic Proteins Inhibit Ciliogenesis of Ependymal Cells in Vitro. Hiraoka K; Inada H; Yanai K; Osumi N Tohoku J Exp Med; 2020 Nov; 252(3):199-208. PubMed ID: 33087680 [TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
31. Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. Tan HL; Glen E; Töpf A; Hall D; O'Sullivan JJ; Sneddon L; Wren C; Avery P; Lewis RJ; ten Dijke P; Arthur HM; Goodship JA; Keavney BD Hum Mutat; 2012 Apr; 33(4):720-7. PubMed ID: 22275001 [TBL] [Abstract][Full Text] [Related]
32. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. Peng Y; Kang Q; Luo Q; Jiang W; Si W; Liu BA; Luu HH; Park JK; Li X; Luo J; Montag AG; Haydon RC; He TC J Biol Chem; 2004 Jul; 279(31):32941-9. PubMed ID: 15161906 [TBL] [Abstract][Full Text] [Related]
33. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. Kim YJ; Lee MH; Wozney JM; Cho JY; Ryoo HM J Biol Chem; 2004 Dec; 279(49):50773-80. PubMed ID: 15383550 [TBL] [Abstract][Full Text] [Related]
36. Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis. Nakayama T; Gardner H; Berg LK; Christian JL Genes Cells; 1998 Jun; 3(6):387-94. PubMed ID: 9734784 [TBL] [Abstract][Full Text] [Related]
37. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848 [TBL] [Abstract][Full Text] [Related]
38. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021 [TBL] [Abstract][Full Text] [Related]
39. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Hata A; Seoane J; Lagna G; Montalvo E; Hemmati-Brivanlou A; Massagué J Cell; 2000 Jan; 100(2):229-40. PubMed ID: 10660046 [TBL] [Abstract][Full Text] [Related]
40. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. Raju GP; Dimova N; Klein PS; Huang HC J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]